Clinical commissioning policy: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

Document first published:: 16 July 2026
Page updated:: 21 August 2026
Topic:: Specialised commissioning
Publication type:: Policy or strategy, Report

Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies (all ages) is recommended to be available as a routine commissioning policy within the criteria set out in this document.

Document

$Clinical commissioning policy: sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies$

Clinical commissioning policy: sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

PDF
236 KB
10 pages

Summary

PDF format. Published 16 July 2026.

Document

$CPAG summary report: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies$

CPAG summary report: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

PDF
332 KB
16 pages

Summary

PDF format. Published 21 August 2026.

Document

$Clinical panel report (January 2024): Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies$

Clinical panel report (January 2024): Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

PDF
178 KB
5 pages

Summary

PDF format. Published 21 August 2026.

Document

$Clinical panel report (April 2024): Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies$

Clinical panel report (April 2024): Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

PDF
152 KB
5 pages

Summary

PDF format. Published 21 August 2026.

Document

$Evidence review: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies$

Evidence review: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

PDF
1 MB
100 pages

Summary

PDF format. Published 21 August 2026.

Document

$Engagement report: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies$

Engagement report: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

PDF
230 KB
5 pages

Summary

PDF format. Published 21 August 2026.

Document

$EHIA: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies$

EHIA: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

PDF
232 KB
15 pages

Summary

PDF format. Published 21 August 2026.